GBV-C: State of the Art and Future Prospects
@article{Giret2012GBVCSO, title={GBV-C: State of the Art and Future Prospects}, author={Mar{\'i}a Teresa Maidana Giret and Esper Georges Kall{\'a}s}, journal={Current HIV/AIDS Reports}, year={2012}, volume={9}, pages={26-33} }
The GB virus C is a common non-pathogenic virus, member of the Flaviviridae family with worldwide distribution. Favorable clinical course and reduced mortality among HIV-infected patients was demonstrated by several studies with patients co-infected with the GB virus C (GBV-C). This potential benefit of GBV-C has been demonstrated in the pre-HAART and post-HAART eras; however, this effect was not observed in all studies and the discrepancy may be due to changes during the course of HIV…
24 Citations
GB Virus C Overview: Insights into Clinical Implication
- Biology, Medicine
- 2013
The GB virus C natural history, epidemiology and its prevalence in different population are discussed, focusing on the disease associations and interaction with HIV infection.
Review of human pegivirus: Prevalence, transmission, pathogenesis, and clinical implication
- Medicine, BiologyVirulence
- 2022
The paper aims to summarize the natural history, prevalence and distribution characteristics, and pathogenesis of HPgV-1, and discuss its association with other human viral diseases, and potential use in therapy as a biovaccine or viral vector.
Use of Flaviviral genetic fragments as a potential prevention strategy for HIV-1 Silencing.
- BiologyJournal of infection in developing countries
- 2016
It is hypothesized that a recombinant GBV-C-based vector can be constructed which expresses several beneficial genetic motifs of the Flaviviridae without causing any side effects while stimulating a wide array of beneficial miRNAs that can more efficiently prevent HIV-1 infection.
Molecular and Clinical Profiles of Human Pegivirus Type 1 Infection in Individuals Living with HIV-1 in the Extreme South of Brazil
- Biology, MedicineBioMed research international
- 2019
Although HPgV-1 infection is persistent, the data suggest that the time of infection does not influence HIV-1 VL or CD4+ T-cell counts in coinfected subjects.
GB virus C infection in Indonesian HIV‐positive patients
- Medicine, BiologyMicrobiology and immunology
- 2013
The prevalence of GBV‐C among HIV‐positive patients in Indonesia is high, and three genotypes were detected, namely genotype 2a, 3 and 6, indicating a shared transmission route with HCV.
Virus against virus (VIVI): a potential solution against HIV/AIDS
- Biology, MedicineInternational archives of medicine
- 2014
Voluntary super-infection of a subject having HIV/AIDS with a virus (GBV-C) is presented, which has been shown to counter, suppress or eradicate the agent responsible for the severe disease.
Prevalence and Clinical Impact of Human Pegivirus-1 Infection in HIV-1-Infected Individuals in Yunnan, China
- BiologyViruses
- 2017
It is revealed that HPgV-1 genotype 7 groups exhibited significantly lower HIV-1 viral load and higher CD4+ cell counts, which suggests that HPGV- 1 genotypes 7 may be associated with a better progression of HIV- 1 disease.
Prevalence and genotypic distribution of GB virus C and torque teno virus among patients undergoing hemodialysis
- Medicine, Biology
- 2017
GMT-C and TTV infections are common in patients undergoing hemodialysis in Yogyakarta, Indonesia, and transmission is likely to be nosocomial in the case of GBV-C infection.
Impact of GB virus C viraemia on clinical outcome in HIV‐1‐infected patients: a 20‐year follow‐up study
- Medicine, BiologyHIV medicine
- 2014
Evaluated patterns in long‐term mortality and morbidity outcomes in patients attending the Hannover Medical School in 2001 found the introduction of antiretroviral therapy (ART) had an impact on the perceived benefits of GBV‐C viraemia.
Discovery of a Novel Human Pegivirus in Blood Associated with Hepatitis C Virus Co-Infection
- Biology, MedicinePLoS pathogens
- 2015
The results indicate that HPgV-2 is a novel bloodborne infectious virus of humans and likely transmitted via the parenteral route.
References
SHOWING 1-10 OF 52 REFERENCES
Infection with GB virus C and reduced mortality among HIV-infected patients.
- Medicine, BiologyThe New England journal of medicine
- 2001
BACKGROUND
The flavivirus GB virus C (GBV-C, also designated hepatitis G virus) was identified in a search for hepatitis viruses, but no disease is currently known to be associated with it. We…
Effect of coinfection with GB virus C on survival among patients with HIV infection.
- Medicine, BiologyThe New England journal of medicine
- 2001
GBV-C infection is common in people with HIV infection and is associated with significantly improved survival, and HIV replication was reproducibly inhibited in cultures of peripheral-blood mononuclear cells by GBV- C coinfection.
Influence of hepatitis G virus (GB virus C) on the prognosis of HIV-infected women
- Biology, MedicineInternational journal of STD & AIDS
- 2011
It is likely that antiretroviral therapy (ART) use in the authors' cohort of 248 HIV-infected women blurred a putative protective effect related to the presence of GBV-C RNA.
Persistent GB virus C infection and survival in HIV-infected men.
- Medicine, BiologyThe New England journal of medicine
- 2004
GBV-C viremia was significantly associated with prolonged survival among HIV-positive men 5 to 6 years after HIV seroconversion, but not at 12 to 18 months, and the loss of GBV- C RNA by 5 to6 years afterAIDS was associated with the poorest prognosis.
Synthetic peptides of hepatitis G virus (GBV-C/HGV) in the selection of putative peptide inhibitors of the HIV-1 fusion peptide.
- Biology, MedicineThe journal of physical chemistry. B
- 2009
The results highlight that the E2(269-286) sequence interacts with the target fusion peptide of HIV-1 and modifies its conformation, which leads to the development of new therapeutic agents for the treatment of AIDS.
GB virus type C infection modulates T-cell activation independently of HIV-1 viral load
- Biology, MedicineAIDS
- 2009
The association between GBV-C replication and lower T-cell activation may be a key mechanism involved in the protection conferred by this virus against HIV-1 disease progression to immunodeficiency in HIV- 1-infected patients.
Diagnostic Value of Anti‐GBV‐C Antibodies in HIV‐Infected Patients
- Biology, MedicineChemical biology & drug design
- 2011
It has been investigated the ability of the synthetic peptides to recognize specific anti‐GBV‐C antibodies in HIV and HCV/HIV co‐infected patients by a peptide‐based ELISA immunoassay and showed that human immunodeficiency virus‐ Infected patients have a significantly higher frequency of anti-GBV-C antibodies than healthy controls.
Viruses within the Flaviviridae Decrease CD4 Expression and Inhibit HIV Replication in Human CD4+ Cells1
- Biology, MedicineThe Journal of Immunology
- 2009
CD4 gene expression is decreased by all human flavivirus NS5 proteins studied, suggesting that CD4 regulation by flaviviruses may interfere with innate and adaptive immunity and contribute to in vitro HIV replication inhibition.
Slower Progression of HIV-1 Infection in Persons with GB Virus C Co-Infection Correlates with an Intact T-Helper 1 Cytokine Profile
- Medicine, BiologyAnnals of Internal Medicine
- 2003
GBV-C RNA levels were determined in all serum specimens collected at the beginning of the study and at the end of follow-up, which indicated that co-infection with hepatitis G virus may slow progression of HIV-1 infection through a mechanism related to T-helper 1 cytokines.
Frequency and genotype of GB virus C among Iranian patients infected with HIV
- Biology, MedicineJournal of medical virology
- 2008
There was no significant difference between patients with and without GBV‐C infection regarding age, sex, route of transmission, viral load, ALT levels, HBV and HCV co‐infection and treatment with antiretroviral drugs.